CD71 Antibody (R17217) is a rat monoclonal IgG2a antibody that detects CD71 in mouse samples through flow cytometry (FCM). CD71, also known as the transferrin receptor (TFR), is a type II membrane glycoprotein that plays a crucial role in iron homeostasis by facilitating cellular uptake of iron through receptor-mediated endocytosis. CD71 exists as a disulfide-linked homodimer, composed of two identical subunits, and binds to transferrin, a serum iron-transport protein, allowing cells to acquire iron necessary for various biological processes, including hemoglobin synthesis and cellular respiration. CD71 is typically expressed at high levels on all proliferating cells, reticulocytes, and erythroid precursors, while CD71 expression is upregulated in activated lymphocytes, monocytes, and macrophages, highlighting CD71′s importance in immune responses and cellular proliferation. CD71 is present on most dividing cells and brain endothelium, indicating CD71′s widespread role in both hematopoiesis and neurobiology. Understanding CD71 function is vital, as mutations in the related transferrin receptor TFR2 can lead to hereditary hemochromatosis type III, an iron overload disorder, emphasizing the significance of iron regulation in health and disease. Anti-CD71 antibody (R17217) is an essential tool for researchers studying iron metabolism and its implications in various physiological and pathological conditions.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
CD71/TFRC/Transferrin Receptor Antibody (R17217) References:
- Modulating effects on CD25 and CD71 antigen expression by lectin-stimulated T lymphocytes in the elderly. | Antonaci, S., et al. 1991. Immunopharmacol Immunotoxicol. 13: 87-100. PMID: 1770220
- Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. | Habashy, HO., et al. 2010. Breast Cancer Res Treat. 119: 283-93. PMID: 19238537
- Cytometric evaluation of transferrin receptor 1 (CD71) in childhood acute lymphoblastic leukemia. | Płoszyńska, A., et al. 2012. Folia Histochem Cytobiol. 50: 304-11. PMID: 22763969
- Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack. | Cinci, M., et al. 2015. Target Oncol. 10: 405-13. PMID: 25395366
- Unique high and homogenous surface expression of the transferrin receptor CD71 on murine plasmacytoid dendritic cells in different tissues. | Lippitsch, A., et al. 2017. Cell Immunol. 316: 41-52. PMID: 28372797
- Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. | Menon, V., et al. 2019. Stem Cells. 37: 1293-1306. PMID: 31381839
- Ultrasound-Targeted Microbubble Destruction Alleviates Immunosuppression Induced by CD71+ Erythroid Progenitor Cells and Promotes PDL-1 Blockade Immunotherapy in the Lewis Lung Cancer Model. | Tan, X., et al. 2021. Front Oncol. 11: 768222. PMID: 34746009
- Unveiling the impact of maternal gestational diabetes mellitus on cord blood CD71+ erythroid cell transcriptome. | Yin, M., et al. 2024. Pediatr Res. 96: 309-312. PMID: 38519796
- The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells. | Bekric, D., et al. 2024. PLoS One. 19: e0302050. PMID: 38603713
- Characterization of immortalized bone marrow erythroid progenitor adult (imBMEP-A)-The first inducible immortalized red blood cell progenitor cell line derived from bone marrow CD71-positive cells. | Kronstein-Wiedemann, R., et al. 2024. Cytotherapy. 26: 1362-1373. PMID: 39001769